Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broader challenges of commercial leadership and what the future might look like as pharma reimagines its commercial model. She also discusses what pharma should do next at a moment when the pace of innovation is incredibly fast and the challenges are unprecedented; why a grow...
Propeller Health brings digital therapeutic expertise together with respiratory care experience to create solutions that improve patients’ lives. General Manager Susa Monacelli joins Maria Whitman to give her perspective on how pharma companies can succeed on the new frontier of digital therapeutics. She also talks about the progress made so far in realizing the potential of digital therapeutics—and what still needs to be done—as well as the learning curves that may create barriers to adoptio...
As head of precision medicine for Merck U.S. Oncology, Dennis Flannelly is thinking ahead. He joins Maria Whitman in this episode to talk about the capability and mindset shifts biopharma needs to make to design, develop and deliver on precision medicine. He also shares the successes he's seen and what he's most excited about as precision medicine evolves. Listen to find out why navigating data will be a key capability in the future and hear advice for biopharma executives who want to succeed...
Biotech CEO/CBO Kris Elverum has worked in large pharma and small biotech firms. He currently acts as a consultant and advisor to both biotech and venture capital companies. Kris joins Maria Whitman on the podcast to share his perspective on precision medicine and the opportunities he sees ahead, as well as how biopharma companies of all sizes can succeed in this sector.
What’s on the minds of global healthcare leaders right now? To find out, in this episode Maria Whitman talks with ZS CEO Pratap Khedkar. The company’s top executive since 2021, Pratap is a recognized healthcare thought leader with expertise across life sciences, data science and artificial intelligence (AI). He shares his insights about what healthcare executives are thinking about, some of the industry’s top challenges and what will shape the rest of the year. Listen to find out why the ind...
Anita Cameron has been living with multiple sclerosis (MS) for more than 30 years. But her condition hasn’t stopped her from learning all she can about MS and the treatments available to her. Anita tells Maria about her patient journey and the support structures that helped her live with an incurable disease.
On this episode of Transforming Biopharma, Maria Whitman hears from Josette Gbemudu, executive director of health equity and social determinants of health at Merck, about how the company is taking action to make its vision of health equity a reality. They also discuss opportunities for biopharma to cooperatively tackle the barriers to systemic change. Highlights: How Merck is mobilizing and empowering teams to create momentum around health equity Why trust is an equity issue T...
Founded in 2012, Flatiron Health helps cancer centers to thrive and deliver better care for patients. CEO Carolyn Starrett joins Maria Whitman to talk about reimagining the infrastructure that supports cancer care and research around the world. She also discusses how the company’s mission has evolved from building software to creating data sets to accelerate and advance new oncology therapies. Listen to hear how we can close the gap between research and cancer care, the role of real-world evi...
Meet Robin Ameny, a passionate patient advocate and a survivor of multiple myeloma. In this episode, host Maria Whitman invites us to see the patient journey through Robin’s eyes. Hear how Robin found the courage to advocate for herself as she faced a life-threatening diagnosis. Learn about the importance of patient support groups and advocacy organizations. Finally, understand how biopharma can better support patients.
Dr. Aarti Shah, former senior vice president and chief information and digital officer at Eli Lilly & Company, knows pharma and technology inside and out. At Eli Lilly, she led an enterprise-wide global organization with responsibilities for information technology, information security, advanced analytics, data science and digital health. Dr. Shah has been named a woman of influence by the Indianapolis Business Journal and was also named one of the fierce women in biopharma by Fierce Phar...
As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company’s mission of improving healthcare in every setting. Learn how she’s working to connect the healthcare ecosystem to bring additional access and benefits to patients. Highlights include: Her view of the opportunities for collaboration to build a better healthcare value chainDiscussion of how we can improve the patient’s experienceAreas where she...
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice president and head of digital technology and innovation at Amgen, believes it’s time to be bold and move faster to capitalize on this opportunity. In this episode they discuss: How Amgen is using its Amgen India Center as an innovation hub to tackle key challengesHow AI and d...
The opportunities to reshape customer engagement have never been greater for pharma, but what role does the customer relationship management (CRM) system play? Kyrsten Musich, vice president of healthcare and life sciences at Salesforce, talks with Maria Whitman about how CRM can enable a more customer-centric approach for life sciences. Highlights include: Why we need to think about the CRM as a system of context, a system of intelligence and a system of activationHow Salesforce is framing t...
Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management (CRM) system. ZS experts Omer Hancer, Namita Powers and Srihari Sarangan talk with Maria Whitman about how companies can get started. Highlights include: · Why now is the pivotal moment for pharma to embrace CRM as a strategic, customer-centric tool · How to orchestrate roles, content and co...
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventions. Maria Whitman gets his perspective on the current state of cell and gene therapy and the promising advancements that can ensure more patients receive these treatments. Highlights include: Why strategic partnerships and digital information are...
If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision. Maria Whitman talks with Juliana Crawford, EVP of emerging strategies at the AHA, to find out how the association is thinking about how policy, science and consumer education can fit together in a broad approach to solving healthcare problems. Highlights include: How th...
Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith of Charter Research on how pharma can forge successful partnerships. While good communication, transparency and collaboration are key, they also discuss how investing in site engagement and understanding the challenges and needs of sites can improve the clinical trial process. Highlights include: What sites have learned...
What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with Paul Ingram, professor of business at Columbia University, to explore the critical role of culture and organizational dynamics in driving successful transformation. Ingram, an expert on leadership and strategy, talks about the relationship between individuals, their values and beliefs and how that connects to an organization...
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing successful strategies and “exploration” of what they might build for the future. He also discusses the role of leaders in driving transformation and the potential of generative AI.